Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicare Rx Winners May Be Determined By Formulary, Policy-Savvy

Executive Summary

Formulary coverage will be crucial for pharmaceutical companies to realize the rewards of the Medicare drug benefit, a former Senate staffer says

You may also be interested in...

Pfizer “Evolves” From Rx To Health Care Company: Fla. Medicaid Is Blueprint

Pfizer plans to follow the blueprint set by its disease management agreement in Florida to forge "creative" agreements with other public and private payors, CFO David Shedlarz told the J.P. Morgan health care conference in San Francisco Jan. 14

AHRQ Comparative Trial Funding Awaits Supplemental Appropriation

The comparative trial/cost effectiveness provisions in the Medicare legislation will require a supplemental appropriation for the Agency for Healthcare Research & Quality

USP To Help Set Formulary Rules Under Medicare Rx Bill

The U.S. Pharmacopeia would play a central role in setting the ground rules for formularies under the Medicare prescription drug bill

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts